| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $7.1M | +48.9% |
| Cost of Revenue | $5.7M | +52.7% |
| Gross Profit | $1.4M | +35.2% |
| R&D Expense | $1.5M | -8.6% |
| SG&A Expense | $3.3M | -8.4% |
| Operating Income | -$3.2M | +18.3% |
| Pre-tax Income | -$2.7M | +4.6% |
| Net Income | -$2.7M | +3.8% |
| EPS (Basic) | -$0.61 |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -11.6% |
| Accounts Receivable | $880K | +1.7% |
| Inventory | $3.8M | -3.9% |
| Current Assets | $9.1M | -9.1% |
| Total Assets | $16.1M | -12.0% |
| Current Liabilities | $9.3M | -2.7% |
| Long-term Debt | $6.9M | -9.8% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | +13.2% |
| Capital Expenditures | $280K | +137.3% |
| Investing Cash Flow | -$113K | -171.1% |
| Financing Cash Flow | $490K | -87.7% |
| Free Cash Flow | -$1.8M | +3.6% |
| +10.3% |
| EPS (Diluted) | -$0.61 | +10.3% |
| Total Liabilities |
| $12.6M |
| -7.8% |
| Stockholders' Equity | $3.5M | -24.7% |